HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...
The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific Rehabilitation ...
Clover Biopharmaceuticals, headquartered in China, has announced that the first participants have been dosed in the Phas...
Treatment effectiveness, health care costs and quality of life outcomes for the two to four percent of Australians with ...
Medical professionals will soon have access to a new device to treat the 3.24 million Australians who suffer chronic pai...
Australia based SpeeDx, a developer of innovative molecular diagnostic solutions, has partnered with Roche, a global pio...
The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital on 10 June 2020 that Australia current...
Australian firm Atomo Diagnostics Limited is pleased to announce it has expanded its existing COVID-19 rapid test p...
Novavax commenced Phase I clinical trial for their COVID-19 vaccine "NVX-CoV2373" a stable prefusion protein antige...
CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ) have announced that...
Thermo Fisher Scientific Inc., the world leader in serving science, and Australia headquartered CSL Limited have announc...
4DMedical, an Australian medical technology company specializing in medical imaging innovation software, announced it ha...
US based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious di...
Vaxine Pty Ltd., Adelaide, Australia announced that it has entered into a formal collaboration with Medytox Inc., a Kore...
The Australian Physiotherapy Association (APA), the 26,000+ member strong industry body for some of the world’s mo...
Australia based Mayne Pharma Group Limited is pleased to announce the launch of butalbital acetaminophen and caffeine (B...
Australian medical supply innovator Big Start is being inundated with orders from around the world as companies seek to ...
Australia based Mesoblast Limited, leader in cellular medicines for inflammatory diseases, announced that it has success...
